Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue

10.1158/1535-7163.MCT-11-0044

Saved in:

Bibliographic Details
Main Authors:	Novotny-Diermayr, V., Sausgruber, N., Loh, Y.K., Pasha, M.K., Jayaraman, R., Hentze, H., Yong, W.-P., Goh, B.-C., Toh, H.-C., Ethirajulu, K., Zhu, J., Wood, J.M.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110765
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110765
record_format	dspace
spelling	sg-nus-scholar.10635-1107652023-10-26T07:44:39Z Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue Novotny-Diermayr, V. Sausgruber, N. Loh, Y.K. Pasha, M.K. Jayaraman, R. Hentze, H. Yong, W.-P. Goh, B.-C. Toh, H.-C. Ethirajulu, K. Zhu, J. Wood, J.M. CANCER SCIENCE INSTITUTE OF SINGAPORE 10.1158/1535-7163.MCT-11-0044 Molecular Cancer Therapeutics 10 7 1207-1217 MCTOC 2014-11-26T09:59:59Z 2014-11-26T09:59:59Z 2011-07 Article Novotny-Diermayr, V., Sausgruber, N., Loh, Y.K., Pasha, M.K., Jayaraman, R., Hentze, H., Yong, W.-P., Goh, B.-C., Toh, H.-C., Ethirajulu, K., Zhu, J., Wood, J.M. (2011-07). Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue. Molecular Cancer Therapeutics 10 (7) : 1207-1217. ScholarBank@NUS Repository. https://doi.org/10.1158/1535-7163.MCT-11-0044 15357163 http://scholarbank.nus.edu.sg/handle/10635/110765 000292498500008 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1158/1535-7163.MCT-11-0044
author2	CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet	CANCER SCIENCE INSTITUTE OF SINGAPORE Novotny-Diermayr, V. Sausgruber, N. Loh, Y.K. Pasha, M.K. Jayaraman, R. Hentze, H. Yong, W.-P. Goh, B.-C. Toh, H.-C. Ethirajulu, K. Zhu, J. Wood, J.M.
format	Article
author	Novotny-Diermayr, V. Sausgruber, N. Loh, Y.K. Pasha, M.K. Jayaraman, R. Hentze, H. Yong, W.-P. Goh, B.-C. Toh, H.-C. Ethirajulu, K. Zhu, J. Wood, J.M.
spellingShingle	Novotny-Diermayr, V. Sausgruber, N. Loh, Y.K. Pasha, M.K. Jayaraman, R. Hentze, H. Yong, W.-P. Goh, B.-C. Toh, H.-C. Ethirajulu, K. Zhu, J. Wood, J.M. Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
author_sort	Novotny-Diermayr, V.
title	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
title_short	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
title_full	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
title_fullStr	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
title_full_unstemmed	Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue
title_sort	pharmacodynamic evaluation of the target efficacy of sb939, an oral hdac inhibitor with selectivity for tumor tissue
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110765
_version_	1781788918237102080

Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue

Similar Items